Beat: PC NAT HC Drug

Advance Progressive Causes / National / Healthcare / Drug Prices

FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. (AP Photo/Ben Margot, File)
They Got Public Funding to Develop a Coronavirus Treatment. Now They Want to Charge $2,340.

A consumer group called it “an outrage” because of the amount taxpayers invested toward the drug's development.

Graphic via Desirée Tapia
The GOP Wants to Repeal the ACA During a Pandemic. Democrats Are Trying to Expand Coverage.

If the Affordable Care Act is struck down, tens of millions of Americans would lose coverage and protections for pre-existing conditions.